Cutler Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Cutler Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-400	Closed	-$1K	–	5736
2022 Q2	$1K	Sell	400 -300	-43%	-$230	﹤0.01%	4822
2022 Q1	$2K	Hold	700	–	–	﹤0.01%	4832
2021 Q4	$1K	Buy	+700	New	+$1.76K	﹤0.01%	5243
2016 Q1	–	Sell	-4,900	Closed	-$13K	–	7401
2015 Q4	$13K	Buy	+4,900	New	+$42.2K	﹤0.01%	3892

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cutler Group's INFI Position: Q3 2023 in Review

Cutler Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 200 shares.

Cutler Group first reported a position in INFI in Q4 2015 and held it in 14 quarters. The position peaked at $20K in Q4 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Cutler Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Cutler Group sold 200 Infinity Pharmaceuticals, Inc. shares in Q3 2023.
Cutler Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
Cutler Group's Infinity Pharmaceuticals, Inc. position peaked at $20K in Q4 2021.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.